Articles tagged "Outcome"

2019 American Transplant Congress
Antirejection Efficacy in De Novo Renal Transplant Recipients Receiving Everolimus with a Reduced-Exposure Calcineurin Inhibitor-Based Regimen: 24-Month Results from the TRANSFORM Study
H. Tedesco Silva¹, F. Citterio¹, M. Henry¹, T. R. Srinivas¹, Y. Watarai¹, S. Steinberg¹, N. Basic-Jukic¹, V. D. Garcia¹, E. Mor¹, V. R. Peddi¹, P. Narvekar², M. P. Hernandez Gutierrez², P. Bernhardt², J. Pascual¹
¹TRANSFORM Study Group, Basel, Switzerland, ²Novartis Pharma AG, Basel, Switzerland
*Purpose: To compare the antirejection efficacy outcomes of an everolimus+reduced-exposure CNI (EVR+rCNI) vs mycophenolic acid+standard-exposure CNI (MPA+sCNI) regimen in renal transplant recipients (RTxRs) from the…
2019 American Transplant Congress
Diminishing Scientific Registry of Transplant Recipients Risk-Adjusted Mortality: Reaction to Flagging, Artifact of Modeling, or Both?
J. A. Gregg¹, K. L. Womer¹, A. Santos¹, S. J. Moore², K. A. Andreoni³
¹Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida, Gainesville, FL, ²Shands Transplant Center, University of Florida, UF Health Shands, Gainesville, FL, ³Department of Surgery, University of Florida, Gainesville, FL
*Purpose: To examine longitudinal trends in SRTR risk-adjusted patient and graft survival rates.*Methods: Current, and archived versions of The Scientific Registry of Transplant Recipients (SRTR)…
2019 American Transplant Congress
Maternal and Pregnancy Outcomes after Living Donor Nephrectomy in a Multistate Cohort
G. S. Lee¹, R. X. Wang², D. O. Walls³, P. P. Reese⁴, D. S. Goldberg⁴, P. L. Abt¹
¹Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, ²Sidney Kimmel Medical College, Philadelphia, PA, ³Surgery, Rutgers Robert Wood Johnson, New Brunswick, NJ, ⁴Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
*Purpose: Studies have demonstrated increased risk of preeclampsia for pregnancies after kidney donation in homogenous populations or single-center studies. Our study aims to delineate maternal…
2019 American Transplant Congress
Improving Living Donor Follow Up
L. Aronoff, V. Nair, C. Flores, M. Bhaskaran, E. Molmenti, A. Fahmy, M. Zhou, E. Grodstein, D. Campbell, C. Literello, L. Teperman
Renal Transplant, Northwell Health, Manhasset, NY
*Purpose: OPTN requires transplant centers follow living donors (LDs) at 6 months, 1 year and 2 years post donation with a minimum threshold of 95%…
2019 American Transplant Congress
Conversion to Belatacept in Kidney Transplant Recipients with Systemic Lupus Erythematosus
I. Carrión Barberà, M. C. Fajardo, D. Tsapepas, J. Gartshteyn, A. Askanase, H. E. Fernandez
Columbia University MC, New York, NY
*Purpose: Lupus nephritis (LN) results in the need for renal replacement therapy (RRT) in 10-30% of LN pts and 30% receive a kidney transplant (KT).…
2019 American Transplant Congress
Personality Traits of Liver Transplant Candidates – Unappreciated Challenges
D. Ladner¹, J. Lai², A. N. Hall¹, E. D. Bastarache¹, A. Daud¹, T. Bogg³, A. Lebsack¹, T. Kalume¹, D. Mroczek¹
¹Northwestern University, Chicago, IL, ²UCSF, San Francisco, CA, ³Wayne State University, Chicago, IL
*Purpose: Liver transplant candidates are chronically ill, requiring complex medical care prior to and after transplant to optimize outcomes. Conscientiousness is one of the Big…
2019 American Transplant Congress
Changing Education Paradigms: Training Fellows for High Stake Procedures
T. Rice¹, H. Lewis¹, M. Cuffy¹, L. Ratner², T. Diwan¹
¹Department of Surgery, University of Cincinnati Medical Center, Cincinnati, OH, ²Department of Surgery, Columbia University, New York, NY
*Purpose: Living kidney donation is unique, as healthy patients are placed at risks inherent with major surgery without physical benefit. The procedure receives intense scrutiny…
2019 American Transplant Congress
The Clinical Outcomes of Kidney Transplant Recipients with Early Graft Failure: A Nationwide Study in South Korea
Y. Kim¹, S. Kwon¹, S. Park¹, J. Moon¹, J. Seon¹, J. Kim¹, M. Yu², K. Han³, D. Kim¹, Y. Kim¹, H. Lee¹
¹Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of, ²Internal Medicine, Hanyang University Medical Center, Seoul, Korea, Republic of, ³Medical Statistics, Catholic University of Korea, Seoul, Korea, Republic of
*Purpose: Despite the graft outcome has been steadily improved over the years, early graft failure (EGF) poses a significant threat to kidney transplant (KT) recipients.…
2019 American Transplant Congress
Early And Late Borderline Lesions Exhibit Differential Outcomes In Renal Transplant Recipients
N. K. Wilson¹, S. Tremblay¹, P. Lee¹, S. Bumb¹, R. R. Alloway¹, A. R. Shields², M. Cardi², E. S. Woodle¹
¹University of Cincinnati, Cincinnati, OH, ²The Christ Hospital, Cincinnati, OH
*Purpose: A major distinguishing factor in the risk of acute rejection episodes that markedly affects graft survival is the timing of the rejection episode. Early…
2019 American Transplant Congress
Outcomes for Lung Transplantation Recipients with Non-Alcoholic Fatty Liver Disease
A. J. Trindade¹, P. Burkett¹, S. El-Chemaly¹, N. Hashemi², T. Thaniyavarn¹, H. R. Mallidi³, H. J. Goldberg¹
¹Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, ²Gastroenterology and Hepatology, Brigham and Women's Hospital, Boston, MA, ³Division of Thoracic and Cardiovascular Surgery, Brigham and Women's Hospital, Boston, MA
*Purpose: Non-alcoholic Fatty Liver Disease (NAFLD) afflicts ~20-40% people in the western world and is a risk factor for comorbidities prevalent in the lung transplant…